Building on lessons learned from the COVID-19 pandemic, there are significant opportunities to expand the use of rapid testing to address many health challenges around the world- from infectious diseases like malaria and HIV to non-infectious health needs like prenatal care. Learn how Abbott is intentionally approaching product development to democratize, decentralize and...
Faced with the COVID-19 pandemic, the healthcare industry had to quickly adapt to confront the rapidly evolving challenges facing its patients, customers, and employees. Learn how three key decisions enabled Merck & Co. to accelerate innovation in 2020 and why these lessons will be critical to future success in addressing the most pressing healthcare challenges.
As new public health threats brew, we need to ensure there is capacity within our health systems to serve the people of this country. There is a strong business case for readiness, but it requires a paradigm shift in how we think about the intersection of routine care, unscheduled care, and the health of the populations we serve.